Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eculizumab for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplantation

NCT01919346 is registered in ClinicalTrials.gov with Heeger, Peter, M.D. as lead sponsor.

NCT NCT01919346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01919346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eculizumab for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplantation
Lead sponsor
Heeger, Peter, M.D.
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2013
Completion date
December 31, 2017
Enrollment
21 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

complement activity, delayed graft function, kidney transplantation